Use of subjective minimizing language at hematology and oncology conferences: A systematic review

AA Abusamak, M Abusamak, M Al-Abbadi… - Journal of Cancer …, 2024 - Elsevier
Background Subjective minimizing language in oncology conferences may undermine
patient-centered care and hinder comprehensive treatment strategies. Subjective terms like" …

Minimal residual disease: premises before promises

B Chin-Yee - Biology & Philosophy, 2024 - Springer
Minimal residual disease (MRD), a measure of residual cancer cells, is a concept
increasingly employed in precision oncology, touted as a key predictive biomarker to guide …

Three lessons from" The Fox and the Grapes" to inform precision oncology in the older adult

G Aleixo, T Voruganti… - Journal of geriatric …, 2025 - pubmed.ncbi.nlm.nih.gov
Three lessons from "The Fox and the Grapes" to inform precision oncology in the older adult
Three lessons from "The Fox and the Grapes" to inform precision oncology in the older adult J …

The Use of Investigator-Assigned Subjective or Judgmental Efficacy and Toxicity Reporting in Early Phase Clinical Trials of Lung Cancer Treatments

WJ Phillips, AS Watson, DR Camidge - Journal of Thoracic Oncology, 2024 - Elsevier
Abstract Introduction Investigator-assigned Subjective or Judgmental Efficacy and Toxicity
(ISJET) reporting represents language used to contextualize efficacy or toxicity data in …

Generalizations in Clinical Trials—Do Generics Help Or Harm?

B Chin-Yee - Kennedy Institute of Ethics Journal, 2023 - muse.jhu.edu
Generalizations in medical research can be informative, but also misleading. Building on
recent work in the philosophy of science and ethics of communication, I offer a novel …